Literature DB >> 8533308

Comparison of adjuvants for immune potentiating properties and side effects in mice.

P P Leenaars1, C F Hendriksen, M A Koedam, I Claassen, E Claassen.   

Abstract

Four types of adjuvants were evaluated as alternatives to the use of Freund's complete adjuvant in mice. The adjuvants evaluated included a water-in-oil emulsion (Specol), a microorganism (Lactobacillus), performed immune-stimulating complexes (ISCOM) containing rabies virus glycoprotein and a saponin, Quil A. The adjuvants and saline were combined with three weak immunogens (a synthetic peptide, a self antigen and a particulate antigen) and given by three different routes (intraperitoneal, subcutaneous and dorsal in the foot). The evaluation was based on clinical observations, behavioural studies, pathological lesions and capacity to support immunological responses to weak immunogens. Lesions were most severe after injection of antigen combined with Freund's adjuvant or Quil A, mild to moderate with Specol and minimal with Lactobacillus, iscom conjugates or saline. Despite pathological changes, no signs of prolonged pain or distress could be demonstrated based on clinical observations and behavioural studies. Minimal immunological responses were found after injection of antigen in combination with saline or Lactobacillus. T-cell activation and high antibody responses were found after injection of antigen-iscom conjugates or antigen in Freund's adjuvant emulsions. After Specol/antigen immunisations T-cell activation was demonstrated and high antibody titres were found except for Specol/self antigen immunisations. Presented data suggest that Specol is a possible alternative to Freund's complete adjuvant for the induction of an immune response against weak immunogens except possibly self antigens, for which performed iscoms seem very suitable.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533308     DOI: 10.1016/0165-2427(94)05413-m

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo.

Authors:  P P Leenaars; H F Savelkoul; C F Hendriksen; N Van Rooijen; E Claassen
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

2.  Effect of pain management on immunization efficacy in mice.

Authors:  April M Kolstad; Ramona M Rodriguiz; Caroline J Kim; Laura P Hale
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-07       Impact factor: 1.232

3.  Hock immunization: a humane alternative to mouse footpad injections.

Authors:  T Kamala
Journal:  J Immunol Methods       Date:  2007-08-28       Impact factor: 2.303

4.  Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks.

Authors:  Chun G Liu; Ming Liu; Fei Liu; Da F Liu; Yun Zhang; Wei Q Pan; Hao Chen; Chun H Wan; En C Sun; Hong T Li; Wen H Xiang
Journal:  Virol J       Date:  2011-06-26       Impact factor: 4.099

5.  Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles.

Authors:  Iraj Khalili; Rahim Ghadimipour; Saeed Sadigh Eteghad; Mohsen Fathi Najafi; Mohammad Majid Ebrahimi; Naser Godsian; Yousef Sefidi Heris; Mohammad Taghi Khalili
Journal:  Jundishapur J Microbiol       Date:  2015-12-26       Impact factor: 0.747

6.  Identification of Molecular Signatures from Different Vaccine Adjuvants in Chicken by Integrative Analysis of Microarray Data.

Authors:  Duk Kyung Kim; Kyeong Hye Won; Seung Hyun Moon; Hak-Kyo Lee
Journal:  Asian-Australas J Anim Sci       Date:  2015-04-06       Impact factor: 2.509

7.  In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.

Authors:  Alexander K Andrianov; Alexander Marin; Ruixue Wang; Ananda Chowdhury; Pragati Agnihotri; Abdul S Yunus; Brian G Pierce; Roy A Mariuzza; Thomas R Fuerst
Journal:  Mol Pharm       Date:  2020-06-23       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.